The purpose of this study was to examine the effects of inactivation of ventral tegmental area (VTA) projection neurons, while sparing fibers of passage, on maternal behavior in rats. Because VTA neurons contain GABA-A and GABA-B receptors, the effects of muscimol or baclofen were studied. Although bilateral injections of either drug into the VTA disrupted maternal behavior, it is likely that they did so through different underlying mechanisms. Muscimol disrupted both retrieval of pups and nursing behavior, while causing stereotyped motor activity. Baclofen disrupted retrieval behavior without affecting nursing behavior, and control injections of baclofen into the region dorsal to VTA were ineffective. The effects of VTA baclofen on maternal behavior are similar to the effects of interference with mesolimbic dopamine (DA) function. The case is made that muscimol probably caused a hyperexcitation of VTA DA neurons through a process of disinhibition. In contrast, baclofen may have depressed the activity of all VTA projection neurons, including VTA DA neurons. Baclofen is a promising tool to explore whether medial preoptic area neurons interact with VTA neurons to control active maternal responses.
There is a strong body of evidence that shows that mesolimbic dopamine (DA) input to the shell region of the nucleus accumbens (NAs) is important for the proactive voluntary components of maternal behavior in rats: (a) electrical lesions of the ventral tegmental area (VTA) disrupt maternal behavior in postpartum rats (Gaffori & Le Moal, 1979; Numan & Smith, 1984) ; (b) 6-hydroxydopamine neurotoxic lesions of the VTA or NA disrupt retrieval behavior without affecting nursing behavior in postpartum rats (Hansen, Harthon, Wallin, Lofberg, & Svensson, 1991a , 1991b ; (c) microinjection of DA receptor antagonists into NAs of postpartum rats disrupts retrieval behavior but does not affect nursing behavior or may even enhance this more reflexive aspect of maternal behavior; interference with DA action on the D1 type DA receptor in NAs is the primary mediator of these effects (Keer & Stern, 1999; Numan, Numan, Pliakou, et al., 2005) ; (d) DA is released into NA and Fos expression is increased in NAs when females are actively engaging in maternal behavior (Champagne et al., 2004; Hansen, Bergvall, & Nyiredi, 1993; Lonstein, Simmons, Swann, & Stern, 1998; Stack, Balakrishnan, Numan, & Numan, 2002) ; and (e) D1-DA receptor agonist microinjection into NAs stimulates the onset of full maternal behavior in rats that have received partial hormone priming and would not normally show immediate maternal responsiveness to pups (Stolzenberg et al., 2007) .
There is also strong evidence that the medial preoptic area (MPOA) and adjoining ventral bed nucleus of the stria terminalis (vBST) regulate the proactive voluntary components of maternal behavior in rats: Lesions to this region eliminate pup retrieval behavior while leaving nursing behavior relatively intact; hormone application to the MPOA/vBST region stimulates maternal behavior (see Numan & Insel, 2003; Numan & Stolzenberg, 2009 , for reviews). The fact that damage to the MPOA/vBST or mesolimbic DA system appears to have similar effects on maternal behavior, disrupting retrieval behavior to a greater extent than nursing behavior, suggests that the two systems may interact to regulate proactive appetitive maternal responses. MPOA/vBST neurons project to the VTA (Numan & Numan, 1996; Simerly & Swanson, 1988) . Furthermore, Fos is expressed in MPOA and vBST during maternal behavior and a proportion of these Fos-containing neurons also project to the VTA (Numan & Numan, 1997) . In addition, a unilateral excitotoxic lesion of MPOA, which does not disrupt maternal behavior (bilateral lesions are necessary), prevents the maternal behavior-induced expression of Fos in the ipsilateral, but not the contralateral, NAs, supporting a functional linkage between these two regions (Stack et al., 2002) . More important, Numan and Smith (1984) provided neurobehavioral evidence for an interaction between the MPOA/vBST and VTA in the regulation of maternal behavior: when the MPOA/vBST was damaged on one side of the brain and the VTA was lesioned on the other, retrieval of pups was severely impaired when compared to females that received unilateral lesions of the MPOA/vBST and VTA located on the same side of the brain.
These findings have given rise to the proposal that the hormonally primed MPOA/vBST influences the occurrence of pupseeking behaviors, retrieval responses, and other proactive maternal responses through its projections to VTA-DA neurons, which give rise to mesolimbic DA input to NA (Numan, 2006; Numan & Stolzenberg, 2008 , 2009 ). The work of Numan and Smith (1984) provides the most important evidence, but in that study, which employed an asymmetrical disconnection design, damage to the MPOA/vBST and VTA was produced with nonspecific lesioning methods that would have damaged fibers of passage. In fact, there is some evidence to support the contention that descending MPOA/vBST efferents that pass through the VTA to reach more caudal brainstem regions may regulate maternal responsiveness (Numan & Numan, 1991 , 1996 . Therefore, the current study represents the initiation of a program that will ultimately test whether neuron specific inactivation of MPOA/vBST neurons on one side of the brain paired with similar inactivation of contralateral VTA neurons is capable of disrupting active maternal responses in rats. Here, we examine whether temporary bilateral neuropharmacological inactivation of VTA neurons, which would spare fibers of passage, would reversibly disrupt proactive maternal responses, particularly retrieval behavior, in postpartum rats.
In addition to containing DA neurons, the VTA contains GABAergic-and glutamate-containing neurons, some of which are local interneurons whereas others are projection neurons (Carr & Sesack, 2000; Johnson & North, 1992; Nair-Roberts et al., 2008; Olson & Nestler, 2007; Swanson, 1982; Van Bockstaele & Pickel, 1995; Yamaguchi, Sheen, & Morales, 2007) . Although the mesolimbic DA system has been implicated in maternal behavior, note that the VTA also gives rise to the mesocortical DA system made up primarily of projections from VTA to the prefrontal cortex (PFC: Swanson, 1982) . The disruption of maternal behavior observed by Numan and Smith (1984) when they paired a unilateral MPOA lesion with a contralateral electrical lesion of the VTA could have been due to disruption of MPOA projections through the VTA, or to disruption of MPOA/vBST interactions with one or more of a variety of VTA neuronal phenotypes. Taking a hierarchical approach, our first step in this study was to develop a method to temporarily inactivate most VTA neurons while sparing fibers of passage. Because VTA DA and non-DA neurons contain GABA-A and GABA-B receptors (Backes & Hemby, 2003; Doherty & Gratton, 2007; Johnson & North, 1992; Kalivas, 1993; Labouebe et al., 2007) and are therefore responsive to the inhibitory effects of GABA, we explored the effects of bilateral injections of either muscimol (a GABA-A receptor agonist) or baclofen (GABA-B receptor agonist) into the VTA on postpartum maternal responsiveness.
General Method

Subjects and Housing
The subjects were nulliparous female rats of the Charles River CD strain (Charles River, Wilmington, MA). At between 70 and 100 days of age, each female was bred with a male of the same strain. On the following morning, females were transferred to individual clear polycarbonate cages (20 ϫ 45 ϫ 20 cm) that contained wood shavings as bedding material. On Day 21 of pregnancy, females were transferred to larger (50 ϫ 40 ϫ 20 cm) individual clear polycarbonate observation cages that also contained wood shavings as bedding material. The floor of each of these maternal observation cages was divided into four equal quadrants by 5-cm high Plexiglas dividers, which prevented pups from crawling from one quadrant to another. The subjects were maintained under a 12-hr reversed light-dark cycle (lights off at 0600), and food and water were freely available. All measurements and behavioral observations occurred during the dark phase with the test rooms illuminated with dim red light.
Stereotaxic Surgery and Intracranial Injection Procedures
Stereotaxic surgery occurred with the rats under Nembutal anesthesia (50 mg/kg ip) and following atropine sulfate pretreatment (0.2 mg/kg ip). After surgery, females were injected with penicillin (50,000 units/kg sc) and the analgesic Rimadyl (5 mg/kg sc), and were placed under a warming lamp to recover. Surgery was performed on Day 14 of pregnancy when bilateral 22-gauge stainless steel guide cannulas (Plastics One, Roanoke, VA) were implanted into the VTA, or into the region 1.6 mm dorsal to the VTA, using coordinates from the DeGroot (1959) stereotaxic atlas and with the mouth bar raised 5 mm. Coordinates from interaural zero for the VTA were A 2.8, L Ϯ 0.75, V 4.3 -4.4. Coordinates for the injection site located dorsal to the VTA were A 2.8, L Ϯ 0.75, V 6.0. The implanted cannulas were occluded with stainless steel stylets that extended 2 mm beyond the end of the guide.
Females were bilaterally injected with various doses of either muscimol or baclofen during the postpartum period. To perform the injections, the experimenter removed the inner stylet from the guide cannula of an awake hand-held rat and replaced it with a 28-gauge injector cannula that extended 2 mm beyond the end of the guide. The injector cannula was attached to a 2 l Hamilton syringe (Reno, NV) with polyethylene tubing, and through the use of a Sage syringe pump, the appropriate volume and dose of the drug was injected over a 60-s interval. The injector remained in place for another 45 s and was removed and the procedure was repeated on the other side of the brain.
Maternal Behavior Morning Measurements and Observations
At about 1000 on each test day, the location of a female, pups, and nest were noted. On Day 1 postpartum all litters were reduced to eight pups (four males and four females) and weighed; maternal weights were also recorded. The pups were returned to the female, four pups each to two quadrants outside the nest area, and a 15-min retrieval test was initiated. On Day 2 postpartum, a similar procedure occurred, except that each female first had the inner stylets of her bilateral guide cannula removed and reinserted. This stylet removal procedure was performed in a room outside the maternal testing room; the female was then returned to the test room and a 15-min retrieval test was initiated 20 min later. Only females who retrieved all of their pups to a common nest site and nursed and groomed the pups within the 15-min test on both Days 1 and 2, and whose pups gained weight during this period, were retained in the study. Almost all females met this criterion, indicating that the implantation surgery and stylet manipulation did not interfere with maternal behavior. The stylet removal procedure was meant to adapt females to the intracranial injections that would occur on subsequent days in the same room. Females remained with their pups throughout the postpartum period and litter and maternal weights were recorded daily.
Detailed maternal behavior observations occurred on the mornings of Days 3, 5, and 7 postpartum, 20 min following intracranial drug injections. These observations consisted of a 20-min retrieval test and a 15-min nursing observation. To initiate the retrieval test, the pups were placed outside the nest area, as described above, and the following was recorded: latency to approach and make snout contact with pups (latency to sniff pups; if a female did not approach and sniff the pups within 5 min, she was subjected to a "forced sniff" wherein the experimenter gently moved her to the location of one group of pups and such females were assigned sniff latencies of 301 s for statistical purposes); number of pups retrieved (retrieval was defined as moving a pup from one quadrant to another); latency to retrieve all pups; latency to retrieve all pups to a common location-the nest area; latency to nurse pups, which was broken down into two observations-latency to hover over pups and latency to crouch over pups (see below for definitions of these nursing postures). In addition to measuring these maternal responses, during the 20-min retrieval test each female's general motor activity was measured: the absolute number of line crosses (movement of all four feet from one quadrant to another) was recorded, including those that occurred during retrieval responses. If a female did not retrieve all of her pups to her nest at the end of the 20-min test, the nonretrieved pups were placed in the nest by the experimenter. Females that did not retrieve all of their pups during the test were assigned retrieval latencies of 1201 s for statistical purposes.
Nursing behavior was measured during the 30 to 45 min interval after the initiation of the retrieval test, at which time all pups were in each female's nest. Each female was observed for about 5 to 10 s every 15 s of the 15-min observation (a total of 60 observations), and it was noted whether she was hovering or crouching over her pups. Usually a female engaged in only a single response during each observation interval. However, if a female transitioned from one behavior to another (e.g., from hover to crouch), the dominant behavior observed during the interval in terms of duration was recorded. One point was given for each positive observation. A female was recorded as nursing if she hovered or crouched over at least two pups. As described by Stern and Johnson (1990) , during hovering a female rests in an upright position, usually on her hind limbs, while her pups are under her ventral surface, and she is usually active, which may involve grooming the pups or self-grooming. If a female was observed grooming her pups during the nursing observation, those instances were recorded. During crouching, also referred to as kyphosis, the female becomes quiescent and uses all four limbs to support a relatively immobile posture with her back either flat or slightly arched during a low crouch or intensely arched during a high crouch. In describing nursing behavior, our analysis emphasizes total nursing duration (hovers plus crouches) and crouching behavior alone. Total nursing duration gives one a measure of the total time the female was over the pups. Crouching behavior is especially important because it facilitates the ability of the young to obtain milk from the dam (Lonstein & Stern, 1997) .
Histology
Females were perfused with saline followed by formalin while under deep Nembutal anesthesia. Forty-m brain sections, cut on a freezing microtome, were stained with cresyl violet. Microscopic examination mapped the location of the cannula injection sites, which were drawn onto the appropriate plates taken from the atlas of Paxinos and Watson (1997;  on the microtome, all brain sections were cut in the plane of this atlas).
Statistics
Data were analyzed with analysis of variance (ANOVA), t tests, and Fisher's LSD test. In cases in which a lack of homogeneity of variances existed, the data were reanalyzed with nonparametric statistics (Friedman's ANOVA, Wilcoxon's test, Mann-Whitney U test). The nonparametric analysis is presented only for those cases in which the results from that analysis differed from the parametric analysis. In most cases, both sets of statistical analyses resulted in the same statistical conclusions. Correlational analyses were performed with Pearson's correlation coefficient. For all analyses, unless otherwise noted, a minimum significance level of p ϭ .05 (two-tailed) was used. The attempt was made to have nine animals per group. However, in different experiments and groups, cases were lost for one or more of the following reasons: mated females were not actually pregnant; misplaced injection sites; females were sickly and did not show adequate maternal behavior on postpartum Days 1 and 2 (in the rare instances in which this occurred, it was associated with nonspecific lesion damage at the injection site).
Method for Experiment 1a
This experiment, which employed a one-way repeated-measures design, explored the effects on maternal behavior of bilateral injections into the VTA of either 0, 25, or 35 ng/side of muscimol hydrobromide (a GABA-A receptor agonist obtained from Sigma Chemical, St. Louis, MO) dissolved in sterile physiological saline (n ϭ 8). The volume of each injection was 0.5 l. The different doses of the drug were administered in a partially counterbalanced order on postpartum Days 3, 5, and 7, and the selected doses were in the range used by other investigators (Arnt & Scheel-Kruger, 1979; Arrati, Carmona, Dominguez, Beyer, & Rosenblatt, 2006; Backes & Hemby, 2008; Corrigall, Coen, Adamson, Chow, & Zhang, 2000; Doherty & Gratton, 2007; Numan, Numan, Schwarz et al., 2005) . The occurrence of normal maternal behavior in females administered the 0 ng dose of the drug on either Day 3, 5, or 7 was taken as evidence that any effects on behavior of muscimol hydrobromide were temporary and reversible. Detailed maternal behavior observations did not occur on Days 4 and 6 postpartum; females remained with their pups, and maternal and pup weights were taken on these days and on Day 8 postpartum.
In preliminary work on the effects of muscimol injections into the VTA, we noted the occurrence of stereotyped motor activity. To quantify such behavior, the motor activity of each female was rated once every 5 min during the retrieving test (four observa-tions) and again during the nursing observation (three observations) using the following scale (Numan & Nagle, 1983) 
Method for Experiment 1b
This experiment was designed like Experiment 1a, except that either 0, 30, or 40 ng/side of R(ϩ)-baclofen hydrochloride dissolved in sterile physiological saline was bilaterally injected into the VTA (n ϭ 8). The volume of each injection was 0.5 l. These baclofen doses are approximately equimolar to the corresponding muscimol doses and were similar to those used by others (Arrati et al., 2006; Backes & Hemby, 2008; Brebner, Phelan, & Roberts, 2000; Corrigall et al., 2000; Doherty & Gratton, 2007; Yun, Wakabayashi, Fields, & Nicola, 2004) .
Method for Experiment 2
This experiment examined the effects on maternal behavior of smaller doses and a smaller volume of baclofen injected bilaterally into the VTA and also examined the anatomical specificity of the observed effects. Using a 2 ϫ 3 experimental design, various doses of R(ϩ)-baclofen hydrochloride were injected bilaterally into either the VTA (Bac-VTA, n ϭ 6) or into the midbrain region 1.6 mm dorsal to the VTA injection site (dorsal control site: Bac-DC, n ϭ 9). Within each independent brain site group, a repeatedmeasures design was used to examine the effects of the following baclofen doses administered in a partially counterbalanced manner over Postpartum Days 3, 5, and 7: 0, 10, and 15 ng/side dissolved in 0.3 l of sterile physiological saline.
To obtain a more detailed measure of the occurrence of nursing behavior during the 20-min retrieval test, once each minute of the retrieval test (20 observations) it was noted whether a female was hovering or crouching over at least two pups.
To determine whether normal maternal behavior occurred by the end of each injection day, on Days 3, 5, and 7 postpartum an afternoon 15-min retrieval test occurred at approximately 5 hr postintracranial injection. These retrieval tests were similar to those that occurred on Days 1 and 2 postpartum and determined whether females retrieved and grouped all their pups into a common nest site and nursed and groomed them.
Results
Muscimol and baclofen injections into the VTA had major disruptive effects on maternal behavior as measured during the morning observation period, and the specific results are described below. In Experiments 1a, 1b, and 2, these effects were shown to be reversible in that females injected with the 0 ng dose of each drug showed normal maternal behavior (see below). In Experiment 2, the temporary effects of baclofen injections into the VTA were also determined at the afternoon observation on Days 3, 5, and 7: irrespective of drug dose and injection site, at 5 hr postinjection all females promptly retrieved their pups to their nests and began nursing them. In addition, in each of the experiments, all mothers maintained their body weights across the postpartum test period, and all pups gained weight across test days. These results indicate that the disruptive effects of intra-VTA muscimol or baclofen on maternal behavior were transitory, showing that these drugs are ideal for a repeated-measures type of analysis.
Experiment 1a
Bilateral injections of muscimol into the VTA disrupted all aspects of maternal behavior during the morning observation period and this disruption was associated with aimless stereotyped motor activity. Figure 1 shows the data on retrieval. As indicated, statistical analyses (one-way ANOVA with repeated measures followed by multiple comparisons with Fisher's LSD test) showed that the 25 ng and 35 ng muscimol treated females showed severe retrieval deficits when compared to the 0 ng treated females. None of the females in each of the muscimol treated groups was able to retrieve all of her pups to the nest during the 20-min retrieval test, while most females in the 0 ng treatment condition completed retrieval in less than 2 min. Table 1 shows data for other aspects of maternal behavior that occurred during the 20-min retrieval test. Although most females approached and sniffed their pups in under 30 s, the muscimoltreated females showed severe deficits in the initiation of nursing behavior. None of the 35 ng treated females hovered over their pups during the 20-min observation, and none of the 25 ng or 35 ng treated females was observed to crouch over their young.
This severe disruption in maternal responsiveness during the retrieval test was related to the fact that the muscimol treated females tended to ignore their pups while engaging in compulsive and aimless stereotyped sniffing and rearing, either over a large area of the cage or restricted to a single part of the cage. Such variability in the area of the cage in which the stereotyped motor activity occurred resulted in variability in the number of line crosses. The data for line crosses and stereotypy are shown in Table 2 . There was a significant overall difference in the stereotypy score, F(2, 14) ϭ 27.70, p Ͻ .001, with both muscimol Figure 1 . Mean ϩSE number of pups retrieved (left ordinate, black bars) and latency to retrieve all pups to the nest (right ordinate, white bars) after microinjection of various doses of muscimol hydrobromide into the ventral tegmental area. For each retrieval measure, groups with different letters differed significantly. treated groups showing this abnormal response. As the muscimol dose increased, the stereotypy became more spatially localized. Therefore, only the 25 ng treated females displayed more cage line crosses than the 0 ng treatment group (Wilcoxin test, p Ͻ .03).
With respect to nursing duration during the 15-min test that began 30 min after the initiation of the retrieval test, as shown in Figure 2 , there was an overall difference in total time spent nursing (the summation of hovers and crouches), F(2, 14) ϭ 11.02, p Ͻ .0013, and crouching, F(2, 14) ϭ 9.28, p ϭ .003, across drug doses: the muscimol treated females showed very little total nursing behavior and the occurrence of crouching was virtually nonexistent. When hovers were examined separately, differences between treatment conditions were not detected. The reason for this finding (see Figure 2) is that most of the nursing that occurred in the 0 ng group was in the form of the crouch posture, while the little nursing performed by the muscimol treated females occurred primarily as hovers. The likely reason for the nursing disruption is that significant stereotyped behavior continued to occur throughout the nursing observation (data not shown), with each muscimoltreated group differing significantly from the 0 ng group ( p Ͻ .01). By the end of the test day (at approximately 1700) however, all females, irrespective of their treatment condition, were nursing all of their young in a nest and were no longer displaying stereotyped motor activity, indicating that the effects of muscimol were temporary within each test day.
Although our measure of stereotypy was crude, we wanted to determine whether a relationship existed between the degree of stereotypy and the amount of maternal behavior that was shown during the 20-min retrieval test and during the 15-min nursing observation. We did these analyses for those females treated with the 25 ng dose of muscimol because in this treatment condition sufficient variability existed in the various measures. For the 20-min retrieval test we detected a significant negative correlation between number of pups retrieved to the nest and stereotypy score (r ϭ Ϫ.64, p Ͻ .05, one-tailed test). For the 15-min nursing observation, a significant negative correlation existed between total nursing duration and stereotypy score (r ϭ Ϫ.84, p Ͻ .01). Therefore, females that showed higher stereotypy scores tended to show poorer maternal behavior. Figure 3A shows the location of the muscimol cannula placements in the VTA, where it can be seen that five of the injection sites were located in the VTA at the level of the interpeduncular nucleus (IPN), while the remaining three were located rostral to IPN. A relationship between injection site location and maternal behavior disruption or stereotypy was not evident. 
Experiment 1b
This experiment was designed just like the previous one, except that various doses of baclofen hydrochloride (0, 30, or 40 ng) were bilaterally injected into VTA. The doses of baclofen employed were approximately equimolar to the muscimol doses. The results with baclofen present a striking contrast to those observed after the muscimol injections: Baclofen severely disrupted retrieval behavior while leaving nursing behavior relatively unaffected. In addition, baclofen treatment did not cause stereotypy but, instead, was associated with decreased locomotor activity. Figure 4 shows the retrieval behavior results. As indicated, the 30 and 40 ng baclofen treated females showed severe deficits. Seven of the eight females in both the 30 and 40 ng treatment conditions did not retrieve a single pup during the 20-min retrieval test while seven of the eight females that received the 0 ng dose retrieved all eight pups. Similarly, none of the females in each of the baclofen treated groups retrieved all of her pups to the nest during the 20-min retrieval test, although most females in the 0 ng treatment condition completed retrieval in less than 3 min.
The typical response of control females during the retrieval test was to promptly retrieve all pups to the nest and begin nursing them. In contrast, the baclofen treated females typically approached one group of four pups and began nursing them outside the nest area without retrieving any pups. Table 3 shows some of the relevant data on behavior other than retrieving during the initial 20-min test. With respect to the latencies to approach and sniff the pups, the Friedman ANOVA test indicated an overall significant difference across drug doses, 2 ϭ 9.91, p ϭ .007; and subsequent comparisons with the Wilcoxon's test indicated that both baclofen treated conditions resulted in longer sniff latencies than the control condition, although the difference in approach latencies between the 0 and 30 ng treatments was minor. Table 3 shows that the three treatment conditions did not differ in their latencies to begin hovering and crouching over their pups. Therefore, once the baclofen-treated females approached their pups, rather than retrieve them they ultimately began to nurse them. The baclofen treated females did not show stereotyped motor activity, but they did show fewer line crosses, F(2, 14) ϭ 24.68, p Ͻ .0001. While the 0 ng treated females made line crosses while retrieving pups, this was not the case for the baclofen treated females, who simply nursed their pups outside the nest area. Figure 5 shows the results from the 15-min nursing observation that began 30 min after the initiation of the retrieval test. For total nursing duration, ANOVA indicated that the differences approached significance, F(2, 14) ϭ 2.46, p ϭ .12; and subsequent LSD tests showed that the 40 ng group nursed less than the 0 ng group ( p Ͻ .05). Differences across treatments were not observed when crouch duration and hover duration were analyzed separately. Therefore, the 30 ng injection of baclofen into VTA almost completely disrupted retrieval behavior without interfering with any aspect of nursing behavior. Figure 3B shows the location of the baclofen cannula placements in the VTA, where it can be seen that two of the injection sites were located in the VTA at the level of the interpeduncular nucleus (IPN), while the remaining six VTA injection sites were located rostral to IPN. However, a relationship between injection site location and retrieval behavior disruption was not evident. Females with injections into either region typically did not retrieve pups but did nurse them.
Experiment 2
The purpose of this experiment was to determine the threshold dose of baclofen in VTA that would disrupt retrieval behavior while leaving nursing behavior intact. In addition, we wanted to provide evidence for the anatomical specificity of this effect. Using a 2 ϫ 3 experimental design (Injection Site ϫ Baclofen Dose) with repeated measures on the second factor, we explored the effects on maternal behavior of bilaterally injecting either 0, 10, or 15 ng of baclofen (in 0.3 l saline/side) into the VTA (Bac-VTA) or into a dorsal control site 1.6 mm above the VTA injection site (Bac-DC). Because of the importance of these results, they will be described in some detail.
For the morning 20-min retrieval test, Figure 6A shows the results for the total number of pups retrieved and Figure 6B shows the latency to retrieve all pups to the nest. For number of pups retrieved, a 2 ϫ 3 ANOVA indicated a significant effect of injection site, F(1, 13) ϭ 11.95, p ϭ .0043; and drug dose, F(2, 26) ϭ 4.30, p ϭ .024; and a significant interaction, F(2, 26) ϭ 3.78, p ϭ .036. Subsequent analyses indicated that number of pups retrieved did not differ across drug doses in the Bac-DC control group. In contrast, within the Bac-VTA group, the 15 ng treated females retrieved significantly fewer pups than did the 0 ng condition. With respect to comparisons between the VTA and DC groups at each drug dose, t tests indicated that the Bac-VTA group injected with 15 ng of baclofen retrieved fewer pups than did its Bac-DC 15 ng counterpart, t(13) ϭ 3.51, p ϭ .0038. With respect to the latencies to retrieve all pups to the nest during the 20-min test, ANOVA again indicated significant injection site ( p ϭ .03), drug dose ( p ϭ .002), and interaction ( p ϭ .007) effects. There were no differences across drug doses in the Bac-DC group, while within the Bac-VTA group, both the 10 ng and 15 ng treated females had significantly longer latencies than did the 0 ng treated females ( p Ͻ .01). Considering comparisons between the VTA and DC groups at each drug dose, t tests indicated that the Bac-VTA groups injected with either 10 or 15 ng of baclofen had longer retrieval latencies than did their respective Bac-DC counterparts, 10 ng comparison: t(13) ϭ 2.87, p ϭ .013; 15 ng comparison: t(13) ϭ 2.57, p ϭ .023.
More descriptive, at the 15 ng baclofen dose, three of six females in the Bac-VTA group did not retrieve a single pup and only one of six eventually retrieved all of her pups to the nest. This should be contrasted with the Bac-DC females receiving the 15 ng injection, in which eight of nine females retrieved all of their pups to the nest site. Females injected with 15 ng into VTA either nursed pups without retrieving them, or retrieved a few pups to the nest and began nursing those without retrieving the remaining pups. Females injected with 10 ng of baclofen into VTA typically retrieved part of their litter, sometimes over an extended period of time, and nursed the pups without completing retrieval of the entire litter. Table 4 shows the latencies to approach and sniff pups and the line crosses shown by females in the VTA and DC groups across the various doses of baclofen. For the most part, there were no major differences in latencies to sniff the displaced pups, with the typical female showing a latency of 10 s or less. Most important, t tests indicated no differences between the VTA and DC injection groups at each drug dose. For line crosses, a significant effect of injection site, F(1, 13) ϭ 14.78, p ϭ .002; and a significant interaction, F(2, 26) ϭ 9.72, p ϭ .0007; was detected. In the Bac-VTA group, the 10 ( p Ͻ .05) and 15 ng ( p Ͻ .01) conditions were less active than the 0 ng females. In the Bac-DC group, the 10 ng treatment condition was more active than the 0 ng injection condition ( p Ͻ .01). Finally, t tests showed that the Bac-VTA 10 ng ( p Ͻ .004) and 15 ng ( p Ͻ .0003) treated females were less active than their respective Bac-DC counterparts. Table 5 shows the data on nursing behavior that occurred during the 20-min retrieval test. Overall, major differences in nursing behavior did not occur. Recall that in this experiment we actually recorded the amount of nursing (hovers plus crouches) during the 20-min test. Because we only took one observation per minute (20 total observations), this data provides only a rough estimate of nursing duration. ANOVA only indicated a significant effect of injection site, F(1, 13) ϭ 5.73, p ϭ .03. The performance of t tests between injection site groups at each drug dose showed that the Bac-VTA group nursed more than the Bac-DC group at the 10 ng Note. Treatment groups are represented by the dose of baclofen injected into each ventral tegmental area (VTA: ng/side). Interquartile ranges are shown in parentheses. Medians or means in the same column that do not share subscripts differ significantly from one another. Figure 6 . (A). Mean ϩSE number of pups retrieved after microinjection of various doses of baclofen hydrochloride into either the ventral tegmental area (Bac-VTA group, black bars) or into a dorsal control site (Bac-DC group, white bars). An asterisk indicates a significant difference between the VTA and DC groups for a particular dose of baclofen. (B). Mean ϩSE latency to retrieval all pups to the nest after microinjection of various doses of baclofen hydrochloride into either the ventral tegmental area (Bac-VTA group, black bars) or into a dorsal control site (Bac-DC group, white bars). An asterisk indicates a significant difference between the VTA and DC groups for a particular dose of baclofen.
dose of baclofen, t(13) ϭ 2.91, p ϭ .01. This difference was the result of a nonsignificant decrease in nursing in the DC group and a nonsignificant increase in nursing in the VTA group. Table 5 also shows the mean latencies to hover over pups and to crouch over pups during the 20-min retrieval test. No differences were detected with respect to the data on hover latencies. For crouch latencies, a significant effect of injection site was detected, F(1, 13) ϭ 8.64, p ϭ .01. Subsequent analyses showed that the Bac-VTA females injected with 15 ng of baclofen initiated crouching with a shorter latency than the Bac-DC females injected with the same dose, t(13) ϭ 2.73, p ϭ .02. The most important aspect of these results is that during the time when baclofen injections into VTA were observed to disrupt retrieval behavior, nursing behavior was not affected and may have even been slightly enhanced. Figure 7 shows the data on total nursing (hovers ϩ crouches) duration and total crouch duration during the 15-min observation that began 30 min after the initiation of the retrieval test. No statistically significant differences were detected. As one would expect from this analysis, when the number of hovers was analyzed separately, no differences were detected. Figure 8 shows photomicrographs of a representative Bac-VTA injection site and a Bac-DC injection site. The VTA injection sites were located similarly to those in Experiment 1, with four injection sites located just rostral to the IPN and two located at the level of the rostral IPN. The DC sites were located dorsally and slightly anterior to the VTA injection sites (due to the fact that the nose bar is raised 5 mm for De Groot, 1959, stereotaxic coordinates), and were just lateral to the ventral part of the periaqueductal gray.
Notes on Pup Grooming in Baclofen Treated Females
Our analyses did not detect major differences in the observed frequency of pup grooming during the 15-min nursing observation for females injected with various doses of baclofen into VTA. Although the baclofen treated females tended to groom their pups less than the 0 ng treated females, these differences did not reach significance. Our measure of pup grooming was not detailed; we only took one observation every 15 s. Given that most females spent about half the nursing observation crouching over their pups, which is a time when pup grooming does not occur, the number of observations made (during hovers) to detect differences in pup grooming was simply not enough to provide the detail needed for accurate statistical measurement.
Discussion
The current study examined the effects of bilateral injections of either muscimol or baclofen into VTA on maternal behavior in postpartum rats. Although both neuropharmacological manipulations disrupted maternal behavior, it is highly likely that they did so by affecting different underlying mechanisms. The muscimol injections disrupted both nursing and retrieval behavior and this disruption was associated with hyperactive stereotyped movements. In contrast, baclofen injections interfered with retrieval behavior while, for the most part, not affecting nursing behavior. The effects on maternal behavior of baclofen injections into the VTA are similar to the effects of certain MPOA lesions (Numan & Insel, 2003) and to the effects of DA receptor antagonist injection into NAs (Keer & Stern, 1999; Numan, Numan, Pliakou, et al., 2005) .
Our initial goal in this study was to examine the effects of temporary inactivation of all VTA neurons, while sparing fibers of passage, on maternal behavior. Because VTA DA neurons and non-DA neurons contain GABA-A and GABA-B receptors (Backes & Hemby, 2003; Doherty & Gratton, 2007; Johnson & North, 1992; Kalivas, 1993; Labouebe et al., 2007) , we thought both muscimol and baclofen would be effective tools. Because of the importance of the mesolimbic DA system for maternal behavior, we wanted our treatments to inhibit VTA DA neurons, and in a dual probe microdialysis study, Westerink, Kwint, and deVries (1996) reported that infusions of both muscimol and baclofen into VTA decrease DA release into NA. However, there is conflicting evidence for the view that muscimol's primary effect is to inactivate all VTA neurons equally. Kalivas reviewed evidence that most GABA-A receptors in the VTA are located on GABAergic interneurons that inhibit VTA DA neurons. Such findings would support the view that the primary effect of intra-VTA muscimol would be to enhance mesolimbic DA activity. Indeed, other studies have reported that muscimol injections into VTA are associated with enhanced release of DA into NA (Doherty & Gratton, 2007; Kalivas, Duffy, & Eberhardt, 1990; Xi & Stein, 1998) . More interesting, Westerink et al. reported that muscimol infusions into the substantia nigra (SN) were associated with increased DA release into the caudate-putamen. Because it is possible that our relatively large doses and volumes of muscimol-VTA injections may have spread to the medial SN, our injections could have resulted in increased activation of both the mesolimbicmesocortical and nigrostriatal DA systems.
Excessive activation of DA systems within the brain is associated with hyperlocomotion and stereotyped motor activity (Costall, Naylor, & Neumeyer, 1975) . Furthermore, selective destruction of VTA GABAergic interneurons is associated with hyperlocomotion (Shank, Seitz, Bubar, Stutz, & Cunningham, 2007) . Similar to our findings, it has been reported that muscimol injections into VTA cause compulsive hyperlocomotion and stereotyped activity (Arnt Note. Within columns, a dagger ( †) indicates a significant difference between injection site groups. Bac-VTA ϭ baclofen injections into ventral tegmental area. Bac-DC ϭ baclofen injections into the midbrain region 1.6 mm dorsal to VTA (dorsal control group).
& Scheel- Kruger, 1979; Kalivas et al., 1990) . More important, both of these studies showed that the hyperactivity caused by intra-VTA muscimol was normalized by systemic treatment of the rats with a DA receptor antagonist. Therefore, it is highly likely that our muscimol injections into the VTA did not inactivate all VTA neurons, but instead caused a hyperactivation of VTA-DA neurons (and possibly other VTA projection neurons and SN-DA neurons), and that the resulting abnormal motor activity resulted in a disruption of both retrieval behavior and nursing because the affected females could not focus their attention on their pups. In support, we found significant negative correlations between the degree of stereotypy and the amount of maternal behavior. In this regard, it is relevant that others have reported that treatments that enhance DA activity in the brain (systemic apomorphine treatment, dopamine transporter knockout mutation, cocaine administration) are associated with hyperlocomotion and stereotypy and with a disruption of maternal behavior in rodents (Spielewoy et al., 2000; Stern & Protomastro, 2000; Vernotica, Rosenblatt, & Morrell, 1999) . In contrast to the research on the effects of muscimol, in vivo microdialysis or voltammetry recordings and electrophysiological recording procedures uniformly show that microinjection of baclofen into the VTA depresses the activity of VTA DA neurons that contribute to the mesolimbic and mesocortical systems (Doherty & Gratton, 2007; Enrico, Bouma, de Vries, & Westerink, 1998; Kalivas et al., 1990; Margolis, Mitchell, Ishikawa, Hjelmstad, & Fields, 2008; Westerink et al., 1996; Xi & Stein, 1998; Yoshida, Yokoo, Tanaka, Emoto, & Tanaka, 1994) . In addition, given that the reinforcing effects of many addictive drugs are due to activation of the mesolimbic DA system, note that intra-VTA baclofen has been found to depress the reinforcing effects of morphine (Tsuji et al., 1996) , and cocaine (Backes & Hemby, 2008; Brebner, Phelan, & Roberts, 2000) . More interesting, intra-VTA muscimol either does not influence the reinforcing effects of cocaine or may actually increase its reinforcing effects (Backes & Hemby, 2008; Lee et al., 2007) . Similarly, intra-VTA baclofen, but not muscimol, has been found to decrease the reinforcing effects of intracranial stimulation of the medial forebrain bundle (Willick & Kokkinidis, 1995) . Finally, either DA-D1 receptor antagonist injection into NAs or baclofen injection into the VTA disrupt operant responses to reward predictive cues (Yun et al., 2004) .
These results strongly support the conclusion that baclofen in the VTA depresses the activity of VTA DA neurons. Because non-DA neurons in the VTA also contain GABA-B receptors (Labouebe et al., 2007) , it is likely that baclofen causes a general depression of all VTA neurons, which would include all projection neurons and all interneurons, although more direct evidence will be needed to prove these points.
In this study we showed that baclofen injections into the VTA, but not into the midbrain region 1.6 mm dorsal to the VTA, disrupted retrieval of pups without interfering with nursing behavior. Intra-VTA doses as low as 10 ng/0.3 l per side were effective. The postpartum females receiving 10 to 15 ng of baclofen into each VTA would typically retrieve some pups and then spend the rest of the time nursing the pups without retrieving the remaining pups during the 20-min test. Females receiving larger doses of baclofen into each VTA (30 ng) showed a total abolition of retrieval behavior, although nursing was still not affected. Maternal behavior has been divided into proactive voluntary components, such as retrieval behavior, which is dependent on forebrain regulation, and more reflexive components such as nursing, which is regulated to a large degree by sensory-motor integration within the brainstem (Numan, 2006; Numan & Insel, 2003; Stern, 1996) . Because baclofen injections into the VTA affected retrieving, but not nursing, it likely produced its effects by blocking the neural projections of the VTA to the telencephalon. One interpretation of the baclofen effect is that it depressed the ability of displaced pups (pups outside the nest site) to serve as salient cues that would normally promote the retrieving response. Another possibility is that baclofen injections into the VTA interfered with behavioral flexibility, so that once a female began nursing her pups it was difficult for her to switch out of the nursing response to continue the retrieval of any remaining pups. These two potential effects are not mutually exclusive. It should be noted that females injected with low doses of baclofen into VTA were aware of their pups and promptly approached them and that they were capable of retrieving a portion of their litter.
Because baclofen injections into the substantia nigra have been found to decrease the release of DA into the caudate-putamen (Westerink et al., 1996) , the possibility exists that our baclofen-VTA injections disrupted proactive voluntary maternal responses in part by spreading to the substantia nigra and depressing the nigrostriatal DA system. We feel, however, that this possibility was not a likely factor that contributed to the results of Experiment 2 because: (a) small doses and volumes of baclofen were injected into VTA, (b) the control DC injections were ineffective, (c) VTA-DA projections to NA are much more important for proactive maternal responses than are the projections of the nigrostriatal system (Keer & Stern, 1999; Numan & Nagle, 1983; Numan & Smith, 1984; Stolzenberg et al., 2007) , and (d) the effects of baclofen injections into the VTA on maternal behavior match the effects of DA antagonist injection into NA (Keer & Stern, 1999; Numan, Numan, Pliakou, et al., 2005) .
The results of these experiments suggest that baclofen injection into the VTA is an effective tool to temporarily and reversibly inactivate the VTA. Future research will investigate whether neuron-specific inactivation of the MPOA on one side of the brain paired with contralateral injections of baclofen into VTA is more effective in disrupting proactive maternal responses than is a procedure that inactivates these two nuclear regions on the same side of the brain, providing strong support for the proposal that MPOA/vBST projections to the VTA provide a route over which the MPOA/vBST can access the telencephalon to affect proactive voluntary maternal responses (Numan & Insel, 2003; Numan & Stolzenberg, 2009 ). Finally, we want to emphasize that we do not view the effects of baclofen injections into the VTA as being specific to maternal behavior. The VTA and the mesolimbic DA system are part of a general motivational system that, when active, increases an organism's responsiveness to a wide variety of biologically significant stimuli (see Numan & Stolzenberg, 2008 , for a review). Indeed, muscimol may have disrupted maternal behavior by making all stimuli salient, while baclofen injections may have done so by decreasing the salience of pup stimuli, as well as other stimuli which promote proactive voluntary responses. Specificity will be arrived at once we link MPOA output to VTA activation (see Numan & Numan, 1991; Numan & Smith, 1984) .
